Cellyan Biotechnology appoints Letao Zhao as independent director, compensation committee chair

• Independent director Mike Yao Zhou resigned from the board, effective Sept. 18, 2026.
• Zhou also stepped down from the audit, compensation, nominating and corporate governance committees; he chaired the compensation committee.
• Letao Zhao joined as independent director, effective Sept. 18, 2026; he also joined the three committees.
• Zhao was named compensation committee chair; his background includes more than 20 years in retail, restaurant operations, and brand management.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellyan Biotechnology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-102776), on September 24, 2026, and is solely responsible for the information contained therein.